{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:23:32Z","timestamp":1773300212298,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003849","name":"IngaBritt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.bcp.2010.11.005","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T04:11:19Z","timestamp":1290399079000},"page":"402-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library"],"prefix":"10.1016","volume":"81","author":[{"given":"Huamei","family":"Forsman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kalder\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Nordling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika Jernmalm","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.11.005_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.iy.12.040194.003113","article-title":"The molecular biology of leukocyte chemoattractant receptors","volume":"12","author":"Murphy","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2010.11.005_bib0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0065-3233(04)68011-9","article-title":"Chemotaxis receptors and signaling","volume":"68","author":"Miller","year":"2004","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.bcp.2010.11.005_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1054-3589(08)60073-3","article-title":"Structure and function of leukocyte chemoattractant receptors","volume":"39","author":"Ye","year":"1997","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1189\/jlb.0905498","article-title":"Ligand recognition and activation of formyl peptide receptors in neutrophils","volume":"79","author":"Fu","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2010.11.005_bib0030","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.2741\/3547","article-title":"NADPH oxidase activity: In the crossroad of neutrophil life and death","volume":"14","author":"Arruda","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2010.11.005_bib0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-065X.2007.00550.x","article-title":"How human neutrophils kill and degrade microbes: an integrated view","volume":"219","author":"Nauseef","year":"2007","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.bcp.2010.11.005_bib0040","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1182\/blood-2005-08-3099","article-title":"Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement","volume":"107","author":"Hayhoe","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcp.2010.11.005_bib0045","doi-asserted-by":"crossref","first-page":"G764","DOI":"10.1152\/ajpgi.00531.2007","article-title":"Annexin-1 modulates repair of gastric mucosal injury","volume":"294","author":"Martin","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0050","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/jpet.108.145821","article-title":"A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects","volume":"328","author":"Hecht","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.11.005_bib0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators","volume":"3","author":"Serhan","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.bcp.2010.11.005_bib0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-3083.2002.01149.x","article-title":"Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1\/LXA4R, is not affected by lipoxin A4","volume":"56","author":"Christophe","year":"2002","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.bcp.2010.11.005_bib0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-3083.2009.02311.x","article-title":"Lipoxin A(4) metabolites\/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors","volume":"70","author":"Forsman","year":"2009","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.bcp.2010.11.005_bib0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/glycob\/cwn081","article-title":"The beta-galactoside binding immunomodulatory lectin galectin-3 reverses the desensitized state induced in neutrophils by the chemotactic peptide f-Met-Leu-Phe: role of reactive oxygen species generated by the NADPH-oxidase and inactivation of the agonist","volume":"18","author":"Forsman","year":"2008","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.bcp.2010.11.005_bib0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1124\/mol.107.037564","article-title":"Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1","volume":"72","author":"Zhou","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2010.11.005_bib0080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/mol.106.033100","article-title":"High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists","volume":"71","author":"Schepetkin","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2010.11.005_bib0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1254\/jphs.09196SC","article-title":"The pyrazolone originally reported to be a formyl peptide receptor (FPR) 2\/ALX-selective agonist is instead an FPR1 and FPR2\/ALX dual agonist","volume":"111","author":"Sogawa","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bcp.2010.11.005_bib0090","doi-asserted-by":"crossref","unstructured":"Kirpotina LN, Khlebnikov AI, Schepetkin IA, Ye RD, Rabiet MJ, Jutila MA, et al. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition. Mol Pharmacol 2010;77(2):159\u201370.","DOI":"10.1124\/mol.109.060673"},{"issue":"14","key":"10.1016\/j.bcp.2010.11.005_bib0095","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmcl.2006.04.068","article-title":"Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents","volume":"16","author":"Burli","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"10\u201311","key":"10.1016\/j.bcp.2010.11.005_bib0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/ci025595r","article-title":"Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching","volume":"43","author":"Abrahamian","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"issue":"46","key":"10.1016\/j.bcp.2010.11.005_bib0110","doi-asserted-by":"crossref","first-page":"43390","DOI":"10.1074\/jbc.M105289200","article-title":"Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly","volume":"276","author":"Cunningham","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-3083.1991.tb01594.x","article-title":"Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality","volume":"34","author":"Boyum","year":"1991","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0120","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0891-5849(95)02189-2","article-title":"Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils","volume":"20","author":"Lundqvist","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bcp.2010.11.005_bib0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-59745-467-4_23","article-title":"Measurement of respiratory burst products generated by professional phagocytes","volume":"412","author":"Dahlgren","year":"2007","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2010.11.005_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1759(99)00146-5","article-title":"Respiratory burst in human neutrophils","volume":"232","author":"Dahlgren","year":"1999","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0135","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.1103595","article-title":"Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin","volume":"75","author":"Betten","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2010.11.005_bib0140","article-title":"A methodological approach to studies of desensitization of the formyl peptide receptor: role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils","author":"Karlsson","year":"2009","journal-title":"J Immunol Methods"},{"issue":"10","key":"10.1016\/j.bcp.2010.11.005_bib0145","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.bcp.2006.02.010","volume":"71","author":"Karlsson","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.bcp.2010.11.005_bib0150","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.4049\/jimmunol.150.10.4591","article-title":"Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E","volume":"150","author":"Wenzel-Seifert","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10753-007-9040-4","article-title":"Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor","volume":"30","author":"Stenfeldt","year":"2007","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.bcp.2010.11.005_bib0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2121-5-50","article-title":"The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide","volume":"5","author":"Fu","year":"2004","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.bcp.2010.11.005_bib0165","doi-asserted-by":"crossref","unstructured":"Forsman H, Dahlgren C. The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide. BMC Cell Biol 2010;11(1):52.","DOI":"10.1186\/1471-2121-11-52"},{"issue":"1","key":"10.1016\/j.bcp.2010.11.005_bib0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1083\/jcb.200202114","article-title":"An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients","volume":"159","author":"Heit","year":"2002","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2567.2004.01884.x","article-title":"The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8","volume":"112","author":"Fu","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2010.11.005_bib0180","doi-asserted-by":"crossref","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464(7285):104\u20137.","DOI":"10.1038\/nature08780"},{"key":"10.1016\/j.bcp.2010.11.005_bib0185","doi-asserted-by":"crossref","unstructured":"Dufton N, Perretti M. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacol Ther 2010;127(2):175\u201388.","DOI":"10.1016\/j.pharmthera.2010.04.010"},{"issue":"13","key":"10.1016\/j.bcp.2010.11.005_bib0190","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/156802609789753608","article-title":"Discovery of selective probes and antagonists for G-protein-coupled receptors FPR\/FPRL1 and GPR30","volume":"9","author":"Arterburn","year":"2009","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10.1016\/j.bcp.2010.11.005_bib0195","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1087057105274532","article-title":"High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands","volume":"10","author":"Young","year":"2005","journal-title":"J Biomol Screen"},{"issue":"3","key":"10.1016\/j.bcp.2010.11.005_bib0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cyto.a.20645","article-title":"Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes","volume":"75","author":"Young","year":"2009","journal-title":"Cytometry A"},{"issue":"23","key":"10.1016\/j.bcp.2010.11.005_bib0205","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1016\/j.bmcl.2007.09.043","article-title":"New \u2018chemical probes\u2019 to examine the role of the hFPRL1 (or ALXR) receptor in inflammation","volume":"17","author":"Frohn","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bcp.2010.11.005_bib0210","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/mol.104.004309","article-title":"A novel nonpeptide ligand for formyl peptide receptor-like 1","volume":"66","author":"Nanamori","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2010.11.005_bib0215","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1476-5381.2009.00483.x","article-title":"Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics","volume":"158","author":"Perretti","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0220","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.129.6.2725","article-title":"Chemotactic factors trigger their own oxidative inactivation by human neutrophils","volume":"129","author":"Clark","year":"1982","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0225","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1189\/jlb.0304144","article-title":"Priming by tumor necrosis factor-alpha of human neutrophil NADPH-oxidase activity induced by anti-proteinase-3 or anti-myeloperoxidase antibodies","volume":"80","author":"Reumaux","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.bcp.2010.11.005_bib0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10067-006-0285-3","article-title":"Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils","volume":"26","author":"Hsieh","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.bcp.2010.11.005_bib0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yexcr.2004.04.006","article-title":"Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe","volume":"298","author":"Almkvist","year":"2004","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.bcp.2010.11.005_bib0240","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1128\/IAI.70.6.2908-2914.2002","article-title":"Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1","volume":"70","author":"Bylund","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.bcp.2010.11.005_bib0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2121-5-21","article-title":"Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils","volume":"5","author":"Bylund","year":"2004","journal-title":"BMC Cell Biol"},{"issue":"9","key":"10.1016\/j.bcp.2010.11.005_bib0250","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.V91.9.3430","article-title":"Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils","volume":"91","author":"Karlsson","year":"1998","journal-title":"Blood"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210008026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:01:12Z","timestamp":1762095672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210008026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0006295210008026"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.11.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2010.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}